Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	1325	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	1394	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	1599	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	2168	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	3719	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	4424	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	4487	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	5082	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	5397	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	5668	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	5797	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	6799	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	7295	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	7875	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	8235	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	8291	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	8575	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	8997	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	9227	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	9311	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	9719	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	9913	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	10239	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	10254	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	11276	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	11341	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	11471	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	11489	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	12760	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	13143	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	13525	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	13984	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	14572	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	15130	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	16879	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	17091	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	17381	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	19333	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	19465	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	19728	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	19966	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	20642	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	21422	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	21462	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	21666	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	22652	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	22783	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	25117	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	26041	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	27566	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	28039	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	33201	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	34592	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	34681	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	35251	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	35289	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	36561	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	37661	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	37687	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	38060	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	39915	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	40766	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	40822	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	41301	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	42049	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	43426	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	43636	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	44108	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	44557	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	45608	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	45955	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	46006	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	46675	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	46872	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	46881	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	48439	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	51592	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	51740	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	52442	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	53801	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	55876	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	59972	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	63033	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	64215	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	64823	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	65397	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	65879	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	67286	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	67733	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	68874	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	95511	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	120431	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-	125676	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRATE (CAS# 77-92-9); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]	1143	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]	1255	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]	1417	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+H)+[-H2O]		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	1067	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	1172	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	1246	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	1418	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	1433	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	1535	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	1713	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	1987	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	2082	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	2189	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	2219	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	2502	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	2649	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	2755	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	2913	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	3248	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	3367	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	3817	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	4065	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	4351	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	4370	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	4599	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	5372	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	5592	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	5730	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	5773	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	6222	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	6805	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	7056	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	7526	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	7633	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	8240	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	8560	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	8626	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	9398	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	9860	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	10370	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	10504	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	10580	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	11121	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	11459	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	12051	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	12053	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	12075	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	12555	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	13638	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	14058	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	15285	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	15367	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	15722	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	15823	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRATE (CAS# 77-92-9); (M+NA)+	15944	Peak area	Control	N	Letrozole	White	Baseline	N	N

Return to search page